Worth reading
58In focus
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
2
Months (postponement of the scheduled completion of PJ1 and PJ4)Wording
Avoiding a definitive answer
How definitive the wording is.This transaction
This projectDate of board resolution26 August 2026
Consideration and expenses
Funding arrangementsThe company is currently negotiating and considering multiple funding options for the funds required to monetize this project.
Impact on Business Performance
The impact on consolidated results for the fiscal year ending September 2027 is currently under review. If any matters requiring disclosure arise, they will be promptly disclosed.
Procedures and assumptions
Conditions Precedent to ExecutionThe revised schedule is the earliest possible schedule, premised on completing the necessary funding by November 2026.
| Item | Details |
|---|---|
| Transaction name | This project |
| Funding arrangements | The company is currently negotiating and considering multiple funding options for the funds required to monetize this project. |
| Impact on Business Performance | The impact on consolidated results for the fiscal year ending September 2027 is currently under review. If any matters requiring disclosure arise, they will be promptly disclosed. |
| Date of board resolution | 26 August 2026 |
| Conditions Precedent to Execution | The revised schedule is the earliest possible schedule, premised on completing the necessary funding by November 2026. |
Items this document does not state (27)
Counterparty nameName of the Subject CompanyBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageGoodwill amountAmount of extraordinary income (loss)Contract DateExecution Date / Effective DateValuation methodologyIndependent valuation institutionSpecial CommitteeManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to difficulties in securing the necessary funding by September 2026, progress on the business has been delayed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.